Clinical Trials Browser

INDUSTRY × Dasatinib × Plasma cell × Clear all

NCT00560352 2017-03-13

Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma

Phase 1 Terminated

16 enrolled 15 charts

Multiple Myeloma

NCT00560391 2016-08-04

Dasatinib in Combination With Revlimid (and Dexamethasone)

Phase 1 Completed

35 enrolled 18 charts

Multiple Myeloma